INS and type 2 diabetes mellitus: Even in patients with T2DM who had a coronary event, where metformin since long has been recommended as the first-line therapy, it might be reasonable to prioritize an SGLT2i, although there are no current direct comparisons between metformin and SGLT2i as regards their insulin-sensitizing effects.